Table 1 Characteristics of the patients
FLA group (N = 19) | Conventional group (N = 22) | P value | |
|---|---|---|---|
Sex (Male/Female) | 11/8 | 13/9 | 0.94 |
Age (median, years) (range) | 68 (52–82) | 70 (56–88) | 0.21 |
Clinical symptoms, n (%) | |||
Jaundice | 11 (57.9) | 12 (54.5) | 0.83 |
Abdominal pain | 10 (52.6) | 9 (40.9) | 0.45 |
Weight loss | 8 (42.1) | 11 (50) | 0.61 |
Anorexia | 7 (36.8) | 6 (27.3) | 0.51 |
Fatigue | 3 (15.8) | 5 (22.7) | 0.87 |
Laboratory data | |||
T-Bil (median, mg/dL) (range) | 6.3 (2.8-13.1) | 5.8 (3.6–17.5) | 0.65 |
Albumin (mean±SD, g/dl) | 3.3 ± 0.72 | 3.5 ± 0.60 | 0.59 |
ALT (median, IU/L) (range) | 56.8 (10.5–1319.0) | 60.4 (12.9–789.8) | 0.43 |
CA19-9 (median, U/mL) (range) | 110.2 (12.6–336.7) | 97.7 (17.6–446.7) | 0.11 |
Causes of strictures, n (%) | 0.97 | ||
Hilar cholangiocarcinoma | 8 (42.1) | 10 (45.5) | |
Gallbladder carcinoma | 4 (21.1) | 5 (22.7) | |
Hepatocellular carcinoma | 3 (15.8) | 4 (18.2) | |
Metastatic cancers | 4 (21.1) | 3 (13.6) | |
Bismuth classification (%) | 0.88 | ||
II | 2 (10.5) | 1 (4.5) | |
III | 4 (21.1) | 5 (22.7) | |
IV | 13 (68.4) | 16 (72.7) | |
TNM stage, n (%) | 0.86 | ||
II | 2 (10.5) | 2 (9.1) | |
III | 3 (15.8) | 2 (9.1) | |
IV | 14 (73.7) | 18 (81.8) | |
Basic diseases, n (%) | |||
Hypertension | 5 (26.3) | 6 (27.3) | 0.95 |
Diabetes | 2 (10.5) | 2 (9.1) | 0.88 |
Cardiovascular disease | 3 (15.8) | 3 (13.6) | 0.85 |
Kidney disease | 1 (5.3) | 3 (13.6) | 0.71 |
Stent size | 0.76 | ||
7Fr+7Fr | 9 (47.4) | 13 (59.1) | |
8.5Fr+8.5Fr | 7 (36.8) | 6 (27.3) | |
7Fr+8.5Fr | 3 (15.8) | 3 (13.6) |